Miranda Neville

Vice President Global Operations & Delivery • Autolus

Miranda Neville, Autolus VP of Global Operations & Delivery has been in the biotech/pharmaceutical industry for the last 23 years. She started her career at Human Genome Sciences in the early 2000s, as the genome mapping was underway, and drugs were being developed with this new technology. Following HGS, she spent several years as a partner at consulting firm AllianceBio. In 2018, her interest in cell & gene therapy led her to join Autolus, a CAR-T cell therapy company. Most of her career has been focused on engineering & capital projects, and project management. Today she leads Engineering & Capital projects team, EH&S, Procurement, Logistics and Patient Scheduling departments for Autolus

Also Speaking

Allyson Berent

Chief Science Officer • Foundation for Angelman Syndrome Therapeutics

Julie G. Allickson

Director, Mayo Clinic Center for Regenerative Medicine & Associate Professor of Regenerative Medicine • Mayo Clinic

Andrew Moreo

Head of Process Development • Andelyn Biosciences

Also Speaking


Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.


Find out more and apply to get involved at the briefings taking place at Advanced Therapies Week.